ea0035p896 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014
Velija-Asimi Zelija
, Burekovic Azra
, Dizdarevic Kemal
Objective: The aim of this single centre prospective open trial was to evaluate the long-term efficacy of octreotide LAR in acromegaly patients and possibility of withdrawal of this therapy.Methods: In total 17 patients with acromegaly diagnosed at Endocrinology Clinic in Sarajevo, somatostatin sensitive (ten females and six males, age range 3765 years, six patients with microadenoma and ten patients with macroadenoma) were treated with octreotide....